rdf:type |
|
lifeskim:mentions |
umls-concept:C0001758,
umls-concept:C0017431,
umls-concept:C0019682,
umls-concept:C0019699,
umls-concept:C0022885,
umls-concept:C0030705,
umls-concept:C0039593,
umls-concept:C0042749,
umls-concept:C0162643,
umls-concept:C0449258,
umls-concept:C0683598,
umls-concept:C1280500
|
pubmed:issue |
3
|
pubmed:dateCreated |
2009-6-24
|
pubmed:abstractText |
Treatment guidelines for multi-experienced HIV patients have recently evolved from aiming to preserve immunity to achieving virological success, largely due to the availability of new antiretroviral drugs and drug classes. To assess the role of viral suppression on clinical progression following a genotypic resistance test (GRT), we have examined a database on patients failing to respond to combined antiretroviral therapy (cART).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1439-0973
|
pubmed:author |
pubmed-author:AntinoriAA,
pubmed-author:Ceccherini-SilbersteinFF,
pubmed-author:Collaborative Group for Clinical Use of the HIV Genotype Resistance...,
pubmed-author:D'ArrigoRR,
pubmed-author:ForbiciFF,
pubmed-author:GoriCC,
pubmed-author:LorenziniPP,
pubmed-author:NarcisoPP,
pubmed-author:PernoC FCF,
pubmed-author:TozziVV,
pubmed-author:TrottaM PMP,
pubmed-author:ZaccarelliMM
|
pubmed:issnType |
Electronic
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
203-9
|
pubmed:meshHeading |
pubmed-meshheading:19274429-Adult,
pubmed-meshheading:19274429-Anti-HIV Agents,
pubmed-meshheading:19274429-Anti-Retroviral Agents,
pubmed-meshheading:19274429-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:19274429-Cohort Studies,
pubmed-meshheading:19274429-Disease Progression,
pubmed-meshheading:19274429-Drug Resistance, Multiple, Viral,
pubmed-meshheading:19274429-Drug Resistance, Viral,
pubmed-meshheading:19274429-Female,
pubmed-meshheading:19274429-Genotype,
pubmed-meshheading:19274429-HIV Infections,
pubmed-meshheading:19274429-HIV-1,
pubmed-meshheading:19274429-Humans,
pubmed-meshheading:19274429-Italy,
pubmed-meshheading:19274429-Longitudinal Studies,
pubmed-meshheading:19274429-Male,
pubmed-meshheading:19274429-Retrospective Studies,
pubmed-meshheading:19274429-Treatment Failure,
pubmed-meshheading:19274429-Viral Load,
pubmed-meshheading:19274429-Viremia
|
pubmed:year |
2009
|
pubmed:articleTitle |
Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.
|
pubmed:affiliation |
Clinical Department, National Institute for Infectious Diseases Lazzaro Spallanzani, Via Portuense 292, 00149, Rome, Italy. zaccarelli@inmi.it
|
pubmed:publicationType |
Journal Article
|